Metagenomi Funding & Investors
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.
metagenomi.coTotal Amount Raised: $456,973,184
Metagenomi Funding Rounds
Series B
$100,000,000
Series B Investors
Catalio Capital ManagementNovo HoldingsSymbiosisModernaLeaps by BayerCorporate Round
$80,000,000
Corporate Round Investors
Ionis PharmaceuticalsSeries B
$175,000,000
Series B Investors
Farallon Capital ManagementPFM Health SciencesIrving InvestorsPura Vida InvestmentsHumboldt FundRa Capital ManagementModernaEventideMarshall WaceNovo HoldingsSurveyor CapitalDeep Track CapitalMillennium ManagementBristol-Myers SquibbFrazier ManagementLeaps by BayerHOF CapitalYaya CapitalGrant
$600,000
Grant Investors
Cystic Fibrosis FoundationSeries A
$75,000,000
Series A Investors
Humboldt FundLeaps by BayerRa Capital ManagementHOF CapitalSozo VenturesAgent CapitalInCube VenturesSeries A
$26,373,182
Series A Investors
BayerHumboldt FundInCube VenturesHOF CapitalAgent CapitalSozo VenturesVictor WangKen Miyoshi
Funding info provided by Diffbot.